logo

For the Inventor, By the Inventor

Kendall Park, NJ, United States of America

Bin Zheng

This inventor holds 13 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Scripps Research Institute, Celgene Corporation. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bin Zheng. Retrieved from https://idiyas.com/inventor/bin-zheng-se2ay0fz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 76.9

 

Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal12 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal4 out of 1,208 
 
Scripps Research Institute
 patents
bronzeMedal1 out of 561 
 
Celgene Corporation
 patents
4. 1 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12760046 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds (2026-10-13),
2. 12565487 - Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide (2026-03-03),
3. 12492217 - Reagents and their use for modular enantiodivergent synthesis of C—P bonds (2025-12-09),
4. 12378246 - Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one (2025-08-05),
5. 12269840 - Process for the preparation of a cyclic dinucleotide (2025-04-08),
6. 12077558 - Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds (2024-09-03),
7. 12049470 - MK2 inhibitors, the synthesis thereof, and intermediates thereto (2024-07-30),
8. 11613554 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds (2023-03-28),
9. 11254679 - Process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide (2022-02-22),
10. 10106560 - Process and intermediates for making tubulysin analogs (2018-10-23),
11. 9518058 - Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide (2016-12-13),
12. 9273067 - Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication (2016-03-01),
13. 7102001 - Process for preparing pyrrolotriazine (2006-09-05),

Title: The Innovative Contributions of Bin Zheng

Introduction

Bin Zheng is a notable inventor based in Kendall Park, NJ (US), recognized for his significant contributions to the field of synthetic chemistry. With a total of 10 patents to his name, he has made remarkable advancements in the development of new compounds and processes.

Latest Patents

Among his latest patents is a groundbreaking method for the synthesis of a complex compound, specifically the synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one. This patent outlines highly efficient methods for preparing key intermediates in the synthesis of the compound, which are broadly applicable and can provide selected components with a variety of substituent groups. Another significant patent involves an improved process for the preparation of a cyclic dinucleotide, which is useful as a STING agonist, involving the use of specific compounds.

Career Highlights

Throughout his career, Bin Zheng has worked with prominent organizations, including Bristol-Myers Squibb Company and The Scripps Research Institute. His work in these institutions has allowed him to contribute to various innovative projects and research initiatives.

Collaborations

Bin Zheng has collaborated with esteemed colleagues, including Martin D Eastgate and Michael Anthony Schmidt. These partnerships have further enhanced his research and development efforts in the field of synthetic chemistry.

Conclusion

Bin Zheng's innovative contributions and extensive patent portfolio highlight his significant role in advancing synthetic chemistry. His work continues to influence the development of new compounds and processes, showcasing the importance of innovation in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…